RAD50 and rectal cancer: Zhou et al. [26] reported 3% of RAD50 non-silent mutations in a large series of 406 Chinese samples of CRC; however, the fraction of rectal cancer was not specified and the relationship with radiotherapy treatment was not investigated [27].